Astragaloside IV is a typical representative of the interactive regulation between immune cell differentiation and metabolic pathways, exerting dual effects by regulating T cell subset differentiation and metabolic pathways
The innovation lies in less frequent dosing, which could enhance adherence and market differentiation for weight management In March 2024, Novo Nordisk announced the acquisition of Cardior Pharmaceuticals, a German biotech firm, for approximately $1.1 billion
Unlike current GLP-1 agonists like semaglutide or dual GIP/GLP-1 therapies like tirzepatide, retatrutide adds glucagon receptor activation for enhanced metabolic benefits
NRBF2 regulates autophagy and prevents liver injury by modulating Atg14L-linked phosphatidylinositol-3 kinase III activity
Skin Texture & Clarity Improvement in overall skin smoothness and translucency with continued treatment cycles
We advise not laying down flat for 4 hours after injections, and avoiding exercise or aerobic activity for 24 hours